Targeting interleukin-6 could help relieve immunotherapy side effects
Researchers have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine interleukin-6 (IL-6).
Read Original Article: Targeting interleukin-6 could help relieve immunotherapy side effects »
